Jane Street
CGON icon

Jane Street’s CG Oncology CGON Stock Holding History

Jane Street’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56M Buy
92,300
+61,300
+198% +$4.01M ﹤0.01% 3340
2026
Q1 		$2.1M Sell
31,000
-9,700
-24% -$550K ﹤0.01% 4987
2025
Q4 		$1.69M Buy
40,700
+27,000
+197% +$1.12M ﹤0.01% 5133
2025
Q3 		$552K Buy
+13,700
New +$398K ﹤0.01% 7643
2025
Q1 		– Sell
-20,100
Closed -$576K – 9535
2024
Q4 		$576K Buy
+20,100
New +$688K ﹤0.01% 6491

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's CGON Position: Q2 2026 in Review

Jane Street sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 3,097 shares — an estimated $202K sold.

Jane Street first reported a position in CGON in Q1 2024 and held it in 5 quarters. The position peaked at $7.39M in Q3 2024. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Jane Street reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 3,097 CG Oncology shares in Q2 2026, an estimated $202K.
  • Jane Street first reported a position in CG Oncology in Q1 2024 and held it in 5 quarters.
  • Jane Street's CG Oncology position peaked at $7.39M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.